Published September 29, 2026 · Category: News

Overview

Cathy Tie, the founder and CEO of Origin Genomics, replenishes nutrients sustaining cells the New York City startup is using to test its technology for repairing defective genes.

Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.

Details

(Image credit: Mackenzie Calle for NPR)

Source

Originally published at www.npr.org.

Related Articles